HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muzafar A Macha Selected Research

Adenoma (Adenomas)

5/2016MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Muzafar A Macha Research Topics

Disease

45Neoplasms (Cancer)
02/2024 - 05/2009
13Squamous Cell Carcinoma of Head and Neck
12/2021 - 05/2009
9Neoplasm Metastasis (Metastasis)
01/2022 - 03/2011
7Carcinogenesis
12/2021 - 05/2009
7Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 10/2012
4Glioblastoma (Glioblastoma Multiforme)
10/2021 - 04/2018
3Inflammation (Inflammations)
01/2022 - 03/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2011 - 11/2010
2Multiple Myeloma
11/2023 - 01/2023
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2016
2Leukoplakia
10/2021 - 07/2010
2Adenocarcinoma
02/2016 - 10/2012
2Mouth Neoplasms (Oral Cancer)
07/2010 - 05/2009
1Chronic Disease (Chronic Diseases)
09/2023
1Osteosarcoma (Osteogenic Sarcoma)
01/2023
1Hematologic Neoplasms (Hematological Malignancy)
01/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2023
1Ovarian Neoplasms (Ovarian Cancer)
01/2023
1Triple Negative Breast Neoplasms
11/2022
1Circulating Neoplastic Cells
01/2022
1Parkinson Disease (Parkinson's Disease)
01/2021
1Adenocarcinoma of Lung
01/2021
1Esophageal Neoplasms (Esophageal Cancer)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Adenoma (Adenomas)
05/2016
1Acquired Immunodeficiency Syndrome (AIDS)
11/2015
1Lymphatic Metastasis
04/2015
1Lung Neoplasms (Lung Cancer)
01/2015
1Basal Cell Carcinoma (Rodent Ulcer)
01/2013

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
04/2021 - 05/2009
7Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2014
6MucinsIBA
08/2018 - 10/2012
4ChemokinesIBA
11/2022 - 01/2021
4MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
4pregna-4,17-diene-3,16-dione (guggulsterone)IBA
12/2013 - 11/2010
3CytokinesIBA
01/2022 - 01/2021
3Temozolomide (Temodar)FDA LinkGeneric
10/2021 - 06/2019
3AfatinibIBA
10/2021 - 03/2017
2Chimeric Antigen ReceptorsIBA
11/2023 - 01/2023
2AntigensIBA
11/2023 - 01/2023
2Ubiquitin-Specific ProteasesIBA
01/2023 - 11/2021
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2023
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 01/2021
2NexusIBA
12/2021 - 02/2021
2Trefoil FactorsIBA
01/2020 - 04/2019
2CateninsIBA
05/2016 - 02/2016
2NicotineFDA Link
03/2011 - 02/2011
1B-Cell Maturation AntigenIBA
11/2023
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
11/2023
1Carotenoids (Carotene)IBA
09/2023
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
01/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023
1CyclinsIBA
01/2023
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2023
1Neoplasm Antigens (Tumor Antigens)IBA
01/2023
1Monoclonal AntibodiesIBA
01/2023
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2023
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1Circulating Tumor DNAIBA
01/2022
1serum P-component (CIt)IBA
12/2021
1Oncogene Proteins (Oncogene Protein)IBA
11/2021
1abexinostatIBA
10/2021
1MethyltransferasesIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1Cyclin D1IBA
10/2021
1palbociclibIBA
10/2021
1curcumolIBA
01/2021
1Circular RNAIBA
01/2021
1CarcinogensIBA
01/2020
1Claudin-1IBA
01/2020
1ClaudinsIBA
01/2020
1CollagenIBA
01/2020
1Fibronectins (Fibronectin)IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2019
1Drug CombinationsIBA
06/2019
1epidermal growth factor receptor VIIIIBA
06/2019
1N-acetyltalosaminuronic acid (NAT)IBA
04/2019
1IntegrinsIBA
08/2018
1Mucin-4IBA
08/2018
1ErbB Receptors (EGF Receptor)IBA
03/2017
1Calcibiotic Root Canal SealerIBA
05/2016
1Glycoproteins (Glycoprotein)IBA
04/2015
1Indicators and Reagents (Reagents)IBA
04/2015
1Phosphotransferases (Kinase)IBA
01/2015
1tyrosine receptor (receptor, tyrosine)IBA
01/2015
1Untranslated RNA (Noncoding RNA)IBA
01/2014
1Formaldehyde (Formol)FDA Link
01/2014
1HhAntag691IBA
01/2013
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
10/2012
1Cadherins (E-Cadherin)IBA
10/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2011
1NF-kappa B (NF-kB)IBA
03/2011
1Interleukin-6 (Interleukin 6)IBA
03/2011

Therapy/Procedure

26Therapeutics
02/2024 - 11/2010
4Radiotherapy
10/2022 - 04/2018
3Precision Medicine
02/2024 - 01/2022
3Immunotherapy
11/2022 - 12/2020
2Adjuvant Chemotherapy
12/2019 - 04/2018
1Drug Therapy (Chemotherapy)
10/2022